Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
KOWA COMPANY,LTD.
🇯🇵
Japan
Country
🇯🇵
Japan
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Tofogliflozin GLP-1 Analogue Combination Trial
Phase 4
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Drug: Tofogliflozin
Drug: GLP-1 analogue
Subscribe
First Posted Date
2015-09-02
Last Posted Date
2020-11-17
Lead Sponsor
Kowa Company, Ltd.
Target Recruit Count
65
Registration Number
NCT02537834
Subscribe
Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC
Phase 3
Completed
Conditions
Hepatic Neoplasm Malignant Recurrent
Interventions
Drug: Placebo
Drug: NIK-333(peretinoin)
Subscribe
First Posted Date
2012-07-16
Last Posted Date
2020-12-02
Lead Sponsor
Kowa Company, Ltd.
Target Recruit Count
616
Registration Number
NCT01640808
Subscribe
Prev
1
2
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy